设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Wiley电子期刊(118)
ProQuest学位论文(1)
Elsevier电子期刊(4912)
SpringerLink电子期刊(5273)
NATURE电子期刊(21)
ACS电子期刊(122)
在“
Elsevier电子期刊
”中,
命中:
4,912
条,耗时:0.0939528 秒
在所有数据库中总计命中:
10,447
条
1.
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-
line
Platinum-based
Chemotherapy
: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
作者:
Andrea Necchi
a
;
andrea.necchi@istitutotumori.mi.it
;
Guru Sonpavde
b
;
Salvatore Lo Vullo
a
;
Daniele Giardiello
a
;
Aristotelis Bamias
c
;
Simon J. Crabb
d
;
Lauren C. Harshman
e
;
Joaquim Bellmunt
e
;
Ugo De Giorgi
f
;
Cora N. Sternberg
g
;
Linda Cerbone
g
;
Sylvain Ladoire
h
;
Yu-Ning Wong
i
;
Evan Y. Yu
j
;
Simon Chowdhury
k
;
Gunter Niegisch
l
;
Sandy Srinivas
m
;
Ulka N. Vaishampayan
n
;
Sumanta K. Pal
o
;
Neeraj Agarwal
p
;
Ajjai Alva
q
;
Jack Baniel
r
;
Ali-Reza Golshayan
s
;
Rafael Morales-Barrera
t
;
Daniel W. Bowles
u
;
Matthew I. Milowsky
v
;
Christine Theodore
w
;
Dominik R. Berthold
x
;
Gedske Daugaard
y
;
Srikala S. Sridhar
z
;
Thomas Powles
aa
;
Jonathan E. Rosenberg
bb
;
Matthew D. Galsky
cc
;
Luigi Mariani
a
;
RISC Investigators
关键词:
Urothelial carcinoma
;
Overall survival
;
Prognosis
;
Platinum
chemotherapy
;
Nomogram
刊名:European Urology
出版年:2017
2.
Chemotherapy
versus endocrine therapy as first-
line
treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis
作者:
Marta Bonotto
a
;
b
;
bonottomarta@gmail.com
;
Lorenzo Gerratana
a
;
b
;
Massimo Di Maio
c
;
Carmine De Angelis
d
;
Marika Cinausero
a
;
b
;
Stefano Moroso
b
;
Monica Milano
d
;
Brigida Stanzione
d
;
Piera Gargiulo
d
;
Donatella Iacono
b
;
Alessandro Marco Minisini
b
;
Mauro Mansutti
b
;
Gianpiero Fasola
b
;
Sabino De Placido
d
;
Grazia Arpino
d
;
Fabio Puglisi
a
;
b
关键词:
Metastatic breast neoplasms
;
Drug therapy
;
Chemotherapy
;
Decision making
;
Treatment outcome
刊名:The Breast
出版年:2017
3.
Salvage High-Dose
Chemotherapy
for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012
作者:
Andrea Necchi
1
;
andrea.necchi@istitutotumori.mi.it
;
Salvatore Lo Vullo
1
;
Marco Bregni
2
;
Giovanni Rosti
3
;
Luigi Mariani
1
;
Daniele Raggi
1
;
Patrizia Giannatempo
1
;
Simona Secondino
3
;
Kathrin Schumacher
4
;
Christophe Massard
5
;
Edward Kanfer
6
;
Karin Oechsle
7
;
Daniele Laszlo
8
;
Mariagrazia Michieli
9
;
Norbert Ifrah
10
;
Melanie Mercier
10
;
Martina Crysandt
11
;
Patrick Wuchter
12
;
Arnon Nagler
13
;
Anders Wahlin
14
;
Massimo Martino
15
;
Manuela Badoglio
16
;
Paolo Pedrazzoli
3
;
Francesco Lanza
17
;
on behalf of the European Society for Blood
;
Marrow Transplantation (EBMT) Solid Tumors Working Party
关键词:
High-dose
chemotherapy
;
Prognostic factors
;
Salvage
chemotherapy
;
Seminoma
;
Survival
刊名:Clinical Genitourinary Cancer
出版年:2017
4.
Efficacy and Safety of Onartuzumab in Combination With First-
Line
Bevacizumab- or Pemetrexed-Based
Chemotherapy
Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer
作者:
Heather Wakelee
1
;
hwakelee@stanford.edu
;
Zanete Zvirbule
2
;
Filippo De Braud
3
;
C. Daniel Kingsley
4
;
Tarek Mekhail
5
;
Thomas Lowe
6
;
Wolfgang Schü
;
tte
7
;
Hervé
;
Lena
8
;
William Lawler
9
;
Fadi Braiteh
10
;
Thomas Cosgriff
11
;
Diego Kaen
12
;
Michelle Boyer
13
;
Jessie Hsu
14
;
See Phan
14
;
Silvia Novello
15
关键词:
Biomarkers
;
Combination therapy
;
MET
;
Phase II clinical trial
;
Progression-free survival
刊名:Clinical Lung Cancer
出版年:2017
5.
The Impact of Systemic Therapy Beyond First-
line
Treatment for Advanced Cervical Cancer
作者:
J. McLachlan
&lowast
;
;
S. Boussios
&lowast
;
;
A. Okines
&lowast
;
;
D. Glaessgen
&lowast
;
;
S. Bodlar
&dagger
;
;
R. Kalaitzaki
&dagger
;
;
A. Taylor
&lowast
;
;
S. Lalondrelle
&lowast
;
;
M. Gore
&lowast
;
;
S. Kaye
&lowast
;
;
S. Banerjee
&Dagger
;
;
susana.banerjee@rmh.nhs.uk
关键词:
Cervical cancer
;
chemotherapy
;
metastatic
;
second-
line
;
targeted therapy
刊名:Clinical Oncology
出版年:2017
6.
Front-
line
treatment of CLL in the era of novel agents
作者:
Tadeusz Robak
a
;
robaktad@csk.umed.lodz.pl
;
Stephan Stilgenbauer
b
;
Stephan.Stilgenbauer@uniklinik-ulm.de
;
Alessandra Tedeschi
c
;
alessandra.tedeschi@ospedaleniguarda.it
关键词:
Chronic lymphocytic leukaemia
;
First-
line
;
Bruton&rsquo
;
s kinase inhibitor
;
Ibrutinib
;
Elderly
;
PI3Kδ inhibitor
;
Idelalisib
;
Venetoclax
刊名:Cancer Treatment Reviews
出版年:2017
7.
New perspectives in the second-
line
treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group
作者:
Diego Cortinovis
a
;
Vanesa Gregorc
b
;
Maria Rita Migliorino
c
;
Maria Ida Abate
a
;
Anna Manzo
d
;
Umberto Malapelle
e
;
Alessandro Morabito
d
;
a.morabito@istitutotumori.na.it
;
alessandromorabito1@virgilio.it
;
alessandro.morabito@uosc.fondazionepascale.it
;
on behalf of The Italian Lung Cancer Working Group
1
关键词:
Non squamous NSCLC
;
Second
line
therapy
;
Nintedanib
;
Ramucirumab
;
Nivolumab
;
Pembrolizumab
;
Atezolizumab
;
Docetaxel
;
Therapeutic strategy
刊名:Critical Reviews in Oncology/Hematology
出版年:2017
8.
Early
chemotherapy
discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study
作者:
Marie Laurent
;
M.D.
;
Ph.D.
a
;
b
;
marie.laurent@aphp.fr
;
Laurent Brureau
;
M.D.
c
;
Mounira El Demery
;
M.D.
d
;
Aude Flé
;
chon
;
M.D.
;
Ph.D.
e
;
Auré
;
lie Le Thuaut
;
M.Sc.
b
;
f
;
g
;
Muriel Carvahlo-Verlinde
;
Pharm.D.
h
;
Sylvie Bastuji-Garin
;
M.D.
;
Ph.D.
b
;
f
;
g
;
Elena Paillaud
;
M.D.
;
Ph.D.
a
;
b
;
Florence Canoui-Poitrine
;
M.D.
;
Ph.D.
1
;
b
;
f
;
g
;
Sté
;
phane Cu
line
;
M.D.
;
Ph.D.
i
;
j
;
1
关键词:
Discontinuation
;
Aged
;
Bladder cancer
;
Metastatic
;
Chemotherapy
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:2017
9.
Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based
chemotherapy
作者:
S. Krug
a
;
b
;
M. Boch
c
;
W. Nimphius
c
;
T.M. Gress
b
;
P. Michl
a
;
patrick.michl@uk-halle.de
;
A. Rinke
b
关键词:
PNEN
;
Chemotherapy
;
5-FU
;
DPD
;
TS
刊名:Pancreatology
出版年:2017
10.
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in
Chemotherapy
-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
作者:
Natasha B. Leighl
1
;
Naiyer A. Rizvi
2
;
Lopes Gilberto de Lima Jr.
3
;
4
;
Wichit Arpornwirat
5
;
Charles M. Rudin
6
;
Alberto A. Chiappori
7
;
Myung-Ju Ahn
8
;
Laura Q.M. Chow
9
;
Lyudmila Bazhenova
10
;
Arunee Dechaphunkul
11
;
Patrapim Sunpaweravong
12
;
Keith Eaton
13
;
14
;
Jihong Chen
15
;
Sonja Medley
15
;
Srinivasu Poondru
15
;
Margaret Singh
15
;
Joyce Steinberg
15
;
Rosalyn A. Juergens
16
;
juergensr@hhsc.ca
;
Shirish M. Gadgeel
17
;
18
关键词:
Combination
;
Epidermal growth factor receptor inhibitor
;
First-
line
therapy
;
Insulin-like growth factor-1 inhibitor
;
Tyrosine kinase inhibitor
刊名:Clinical Lung Cancer
出版年:2017
1
2
3
4
5
6
7
8
9
按检索点细分(4912)
题名(687)
关键词(250)
文摘(3806)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.